ArticleJournal of translational medicine2022

Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathways.

Fei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.